Gastrointestinal malignancy in cystic fibrosis.

Natasha Emily Hough, Stephen James Chapman, William George Flight

Journal: Paediatric respiratory reviews 2021;35():90-92

PMID: 32505496

Full Text on Elsevier Science View on PubMed

Abstract

Cystic fibrosis (CF) is a multisystem disease affecting the gastrointestinal (GI) tract as well as the lungs. As survival has increased significantly over the past few decades, complications not seen previously have become apparent. There is an overall increased rate of malignancy in CF, particularly from the GI tract and in the post-transplant population. The most common sites of malignancy are the pancreatico-biliary and digestive tract, as well as an increased rate of testicular cancer. Using an illustrative case of metastatic oesophageal malignancy which initially appeared to be hepatic in origin, we have reviewed the literature surrounding malignancy in CF with a particular focus on the GI tract.

Address: Oxford Adult Cystic Fibrosis Unit, John Radcliffe Hospital, Oxford, Headley Way, Oxford OX3 9DU, United Kingdom. Electronic address: [email protected].; Oxford Adult Cystic Fibrosis Unit, John Radcliffe Hospital, Oxford, Headley Way, Oxford OX3 9DU, United Kingdom.

DOI: 10.1016/j.prrv.2020.03.002

Link outs

Free resources

Medical:

Miscellaneous:

https://assays.cancer.gov/CPTAC-68

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-HLA-B-1

Subscription / membership required

Full Text Sources:

MeSH Terms: Adenocarcinoma, Clear Cell, Adult, Antineoplastic Combined Chemotherapy Protocols, Bone Neoplasms, Cystic Fibrosis, Esophageal Neoplasms, Fatal Outcome, Fluorouracil, Gastrointestinal Neoplasms, Humans, Leucovorin, Liver Neoplasms, Male, Organoplatinum Compounds